Changes in antidepressant metabolism and dosing across pregnancy and early postpartum - Wikidata - wikimedia - TriplyDB

Changes in antidepressant metabolism and dosing across pregnancy and early postpartum

Changes in antidepressant metabolism and dosing across pregnancy and early postpartum

http://www.wikidata.org/entity/Q36692162

about

Postpartum psychiatric disorders: Early diagnosis and management Placental transfer of antidepressant medications: implications for postnatal adaptation syndrome Pharmacotherapy of postpartum depression: an update Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review Antidepressant use in pregnancy: a critical review focused on risks and controversies Prenatal antidepressant exposure: clinical and preclinical findings.Stress sensitive female macaques have decreased fifth Ewing variant (Fev) and serotonin-related gene expression that is not reversed by citalopram.Ethical issues in perinatal mental health research Pharmacogenetics and individualizing drug treatment during pregnancy.Returning to tricyclic antidepressants for depression during childbearing: clinical and dosing challenges.Forced swim test behavior in postpartum rats Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.Interactions of corticotropin-releasing factor, urocortin and citalopram in a primate model of stress-induced amenorrhea.Lactating mother and psychotropic drugs.Treatment of postpartum depression: clinical, psychological and pharmacological options Biologically based treatment approaches to the patient with resistant perinatal depression.Disposition of chiral and racemic fluoxetine and norfluoxetine across childbearing.Mother-infant antidepressant concentrations, maternal depression, and perinatal events Effect of pregnancy on the disposition of 2,2',3,5',6-pentachlorobiphenyl (PCB 95) atropisomers and their hydroxylated metabolites in female mice COLLABORATIVE CARE FOR PERINATAL DEPRESSION IN SOCIOECONOMICALLY DISADVANTAGED WOMEN: A RANDOMIZED TRIAL.Prescribing without evidence - pregnancy.A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4 Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy.Anhedonia in postpartum rats Altered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized mice.Factors affecting the development of adverse drug reactions (Review article)Adherence of antidepressants during pregnancy: MEMS compared with three other methods.Family history, not lack of medication use, is associated with the development of postpartum depression in a high-risk sample.Unipolar depression during pregnancy: nonpharmacologic treatment options.Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence.A pharmacological approach to panic disorder during pregnancy.Use of psychotropic drugs during pregnancy and breast-feeding.Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.Treatment with antipsychotics in pregnancy: Changes in drug disposition.5-HT2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional 'serotonin-specific reuptake inhibitors'.Quetiapine Dose Adjustments in Pregnant and Postpartum Women With Bipolar Disorder.Increased incidence of non-alcoholic fatty liver disease in male rat offspring exposed to fluoxetine during fetal and neonatal life involves the NLRP3 inflammasome and augmented de novo hepatic lipogenesis.Pregnancy and pharmacogenomics in the context of drug metabolism and response.

P2860

Q26795414-5C3F44C6-5077-4E15-951C-04A79FA854E0 Q26999391-167EA727-83F9-4CBF-B151-E88106BB74B2 Q27010062-9DA0DF7B-7845-4B59-BBD3-75F329839187 Q27027293-FAA13263-E9A1-440D-9867-14BDD3BAB72B Q28109657-C002704C-213F-430B-BA10-85F88961E85F Q28281407-6275E610-B569-45AC-9BDD-73345D8184A5 Q30415540-BE5B6919-A52B-4CDE-B9EE-F2D19B5BD2A1 Q30490951-360D1D40-2A7F-47F7-AC05-31716E767962 Q33738831-F7AB1182-1046-4EEC-9F07-9F5FADA0E373 Q33781272-F534647C-6DF6-42AF-B767-1E1A13EC86CD Q33976001-2C75DF8C-853C-430F-BB5A-166B5CEB066B Q34151369-311A2859-20E7-49E7-B8A0-7C63F5F7DA94 Q34483257-F2DD5D6D-ACBB-4018-8FD5-7F04229E7F0D Q34515559-CE892FEF-F258-42B8-88B6-085295BEB442 Q34543929-11659C4E-E3AD-4068-BC72-D0E8251897C8 Q34574118-55D9FB42-646C-46C7-9E41-9A6C01E29C4B Q34799159-224DC470-7E87-4AB7-A882-9894B9D9279E Q35030007-EB5A2D31-0A6D-4598-9CC7-04D28F0E7EFE Q35172179-6CF67249-1705-414E-B290-5B4B8FCD8B36 Q36083543-B2B20183-253B-4E64-AAF5-0150B6D50692 Q36240467-4D5D0593-8920-4AF1-B836-FB91DED6667D Q36336002-F3E34F95-DBCE-41C0-A499-8D16955F5905 Q36390289-9C871B42-04A6-4E31-A871-A6EAE243324D Q36810933-5CAB33E1-0703-4271-A853-ABE611529EE5 Q37480756-F9C00445-7932-49F9-8F92-C8E4855AB8DE Q37563369-38CF2AD7-B2DF-4C98-B553-A94775A680C0 Q37631543-3395FB1E-F928-4415-A995-4153CB2FD918 Q37634873-88AC776F-A624-46C0-8E8C-75B4297FEB42 Q37666024-9031CE78-59B9-4FA8-AEC7-4137BAC1C771 Q37769525-3289AAAD-1D4A-4208-94F7-360706987A8E Q38215072-8902FB91-24C9-4351-821C-4FF9AB30BCB7 Q38305749-4FCCF1EB-C99B-4B04-90BB-0B3294837565 Q38516009-9021660C-6438-4E8C-B2E9-2A50ADDA7750 Q38582061-F1A3B887-669D-41BD-BF84-F9FA2BE7D874 Q38678838-FB82790E-EF13-4F70-968D-61BF8413961F Q38712679-6E424EF5-CE30-40EF-B5CA-38020DA27164 Q42905649-A8670D78-6F35-4BDF-B4BC-AD6567829E58 Q47690894-574E9D6E-8438-43D3-9C66-64B68FE85D76 Q47709525-DC68C4D7-415B-48C0-8C07-19733E3BC278 Q54659609-033B5D92-790E-43B0-AA0D-C05F49447D42

P2860

Changes in antidepressant metabolism and dosing across pregnancy and early postpartum

http://www.wikidata.org/entity/Q36692162

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Changes in antidepressant metabolism and dosing across pregnancy and early postpartum

@ast

Changes in antidepressant metabolism and dosing across pregnancy and early postpartum

@en

type

label

Changes in antidepressant metabolism and dosing across pregnancy and early postpartum

@ast

Changes in antidepressant metabolism and dosing across pregnancy and early postpartum

@en

prefLabel

Changes in antidepressant metabolism and dosing across pregnancy and early postpartum

@ast

Changes in antidepressant metabolism and dosing across pregnancy and early postpartum

@en

P1433

Q36692162-12F2FC6D-05AC-4BA4-9830-ED04CACB5947

P1476

Q36692162-ACF144B5-B5D9-4D5B-8128-91E057D27C60

P2093

Q36692162-3FD0ACB8-CADF-4A13-9CFC-43644FCE3834

Q36692162-95A45453-80C4-4F49-A1F0-A40BB3D375F3

Q36692162-C788C406-401F-4DFF-995F-CD1E7DF73603

Q36692162-EDA672AB-5CFC-4545-B936-4D8AFFA1FB02

P2860

Q36692162-000A6D70-68C3-4E4B-9A1E-BBFF798F5A75

Q36692162-049D088D-79B9-4895-AFA7-4811A9F51BFA

Q36692162-0513FB4A-7258-4A22-B01A-4D52EE2BF73E

Q36692162-087E5896-14EB-4000-B86C-9849FEFE3E68

Q36692162-0F098FED-7B5B-407B-A528-E3196322A6FE

Q36692162-1B1265C2-703A-4E51-8FF5-DA0C4DC3616D

Q36692162-1EE85817-33AD-4629-9E8A-A131A105F637

Q36692162-24476231-CAE6-4C8E-B033-59DCE6C430EB

Q36692162-24DAF06E-453B-4A21-9EE4-73F3A95B3D0E

Q36692162-2743AEB4-68C9-4329-85C6-F370ECF40AF8

P304

Q36692162-86942B46-8636-4CAE-AAF9-B9BF8300D806

P31

Q36692162-A5862AA5-24BC-4E65-AE41-DCD6973B9CD7

P356

Q36692162-75641CF2-A55D-4C8F-937C-03F31792C344

P433

Q36692162-14178A64-CF90-42A6-BC85-8549D72A4C26

P478

Q36692162-2EE2B456-6E79-4222-BF6F-69947383BB7E

P577

Q36692162-8AEF3443-8CB7-4C20-869F-E4E9E4017773

P5875

Q36692162-94ED9D42-8A0E-4F1D-92C7-2018E6C2E83E

P698

Q36692162-F7C1410E-F2AB-46B8-B6C3-28C20FBE9B61

P921

Q36692162-36A59967-83DD-4F72-928B-C78247276291

P932

Q36692162-CA548FFA-50B3-44F4-AC58-3DDBCA5DEE53

P356

P1433

The Journal of Clinical Psychiatry

P1476

Changes in antidepressant metabolism and dosing across pregnancy and early postpartum

@en

P2093

Dorothy K Sit

http://www.w3.org/2001/XMLSchema#string

James M Perel

http://www.w3.org/2001/XMLSchema#string

Joseph C Helsel

http://www.w3.org/2001/XMLSchema#string

Katherine L Wisner

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer

Clinical implications of the pharmacology of sertraline

A new depression scale designed to be sensitive to change

Pharmacokinetics during pregnancy: evidence-based maternal dose formulation.

Gender-related differences in pharmacokinetics and their clinical significance.

Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro.

Citalopram--a review of pharmacological and clinical effects.

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

P304

652-658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4088/JCP.V69N0419

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5427094

http://www.w3.org/2001/XMLSchema#string

P698

18426260

http://www.w3.org/2001/XMLSchema#string

P921

postpartum period

P932

2408825

http://www.w3.org/2001/XMLSchema#string